西纳二酸通过抑制KRT6A/S100A2轴而表现出抗结直肠癌的作用
Yan Yang1,2,3, Zhirui Zeng1,2, Lian Li1,2
1Transformation Engineering Research Center of Chronic Disease Diagnosis and Treatment, Guizhou Medical University, Guiyang, Guizhou, China.
Cancer biology & therapy
|August 30, 2023
概括
西纳硫酸 (ST) 通过抑制细胞生长和转移,对结直肠癌 (CRC) 产生抗癌作用. 这项研究揭示了ST针对KRT6A/S100A2通路,提供了潜在的新型CRC治疗方法.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 西纳二酸盐 (ST) 是一种十字花植物的化物,具有已知的抗炎和抗恶性特质.
- ST对结直肠癌 (CRC) 的特定影响和分子机制在很大程度上仍未被描述.
研究的目的:
- 为了研究西纳硫酸盐 (ST) 对结直肠癌 (CRC) 细胞的抗癌作用.
- 阐明ST在CRC中的作用背后的分子机制,重点关注基因表达和通路调制.
主要方法:
- 在体外测试中评估了CRC细胞的增殖,殖民地形成,细胞亡,细胞循环,入侵和迁移.
- 在ST治疗后,RNA测序确定了差异表达基因 (DEGs).
- 在体内异种移植模型中评估了ST的疗效和对瘤生长的分子影响.
主要成果:
- 在实验室中,ST显著抑制了CRC细胞的增殖,殖民地形成,并诱导了亡,在G1阶段阻止了细胞.
- ST抑制了CRC细胞的入侵和迁移,RNA测序显示了化途径激活的减少.
- ST降低了KRT6A和S100A2的表达,这与良好的CRC患者预后相关;KRT6A过度表达抵消了ST的影响.
- 在体内,ST抑制了瘤生长,并降低了KRT6A和Ki67的表达.
结论:
- 西纳二酸盐 (ST) 显示出显著的抗CRC特性,通过抑制KRT6A/S100A2轴的介导.
- 在体外和体内,ST有效抑制CRC细胞的增殖,入侵和迁移.
- ST代表了结直肠癌治疗的潜在治疗剂.
更多相关视频
相关概念视频
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
198
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
198
01:15Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
01:29Drugs for Treatment of Ulcerative Colitis in IBD
173
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
173